AC Immune
ACIU
47 hedge funds and large institutions have $102M invested in AC Immune in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 11 closing their positions.
67% more call options, than puts
Call options by funds: $1.12M | Put options by funds: $671K
3% more capital invested
Capital invested by funds: $99.7M → $102M (+$2.65M)
1.27% less ownership
Funds ownership: 28.83% → 27.56% (-1.3%)
11% less funds holding
Funds holding: 53 → 47 (-6)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$12.3M |
| 2 |
AA
ALPS Advisors
Denver,
Colorado
|
+$663K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$589K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$413K |
| 5 |
Squarepoint
New York
|
+$251K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.56M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$4.66M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$2.26M |
| 4 |
Millennium Management
New York
|
-$1.29M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$977K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$131K | -26,828 | Closed |
|
52
Citadel Advisors
Miami,
Florida
| – | -$122K | -23,970 | Closed |
|
|
ECM
53
ExodusPoint Capital Management
New York
| – | -$79K | -16,100 | Closed |
|
54
Assenagon Asset Management
Senningerberg,
Luxembourg
| – | -$59K | -12,042 | Closed |
|
|
FDCDDQ
55
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$37.9K | -7,744 | Closed |
|
56
JP Morgan Chase
New York
| – | +$168 | +33 | New |
|
ACIU Hedge Fund Activity: Q4 2020 in Review
47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2020, worth a combined $102M — up 2.7% from $99.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ACIU and 6 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 12 added.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $12.3M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $7.56M sold.
- 47 institutional investors held AC Immune (ACIU) as of Q4 2020, down from 53 in Q3 2020.
- Funds reported $102M of AC Immune stock for Q4 2020, up 2.7% quarter-over-quarter.
- 6 funds opened new AC Immune positions in Q4 2020 and 11 closed out, a net change of -5 holders.
- The largest AC Immune buyer in Q4 2020 was EcoR1 Capital, an estimated $12.3M added.
- The largest AC Immune seller in Q4 2020 was Avidity Partners Management, an estimated $7.56M sold.
Based on aggregated 13F filings for Q4 2020.